Back to 2025 Posters
EARLY AND INTRAOPERATIVE OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY (ESG) IN A HIGH VOLUME CENTER.
Cesar D. Quiroz Guadarrama
*2, Felipe Giron
1, martin edgardo rojano rodriguez
2, Gontrand lopez nava
3, Natan Zundel
41General Surgery, Fundacion Santa Fe de Bogota, Bogota, Colombia; 2Clinica del Noreste, Hermosillo, Sonora, Mexico; 3Hospital de Sanchinarro, Madrid, Madrid, Spain; 4Florida International University, Miami, FL
Introduction:
Endoscopic Sleeve Gastroplasty (ESG) has emerged as a minimally invasive bariatric procedure with promising outcomes in weight loss and metabolic improvement. High-volume centers are critical in assessing the procedure’s safety and efficacy, providing a benchmark for its integration into routine practice. This study evaluates the early and intraoperative outcomes of ESG in a high-volume bariatric center during 2024.
Objective:
To describe the patient characteristics, clinical experience, and early intraoperative outcomes of Endoscopic Sleeve Gastroplasty (ESG) in a high-volume bariatric center in 2024.
Methods:
A retrospective observational study was conducted using a prospectively maintained database. The study included all patients who underwent ESG between January and December 2024. Data collected included baseline demographics, intraoperative findings, and postoperative outcomes. Variables analyzed comprised operative time, procedural details, complications, and endoscopic findings. Statistical analyses were performed as appropriate to variable characteristics.
Results:
Out of 472 procedures performed, 400 ESG cases were analyzed after excluding five cases due to incomplete records. The cohort comprised 31.25% males and 68.75% females, with a mean age of 36.76 ± 8.9 years. The mean preoperative body mass index (BMI) was 36.07 ± 5.1 kg/m2.
A total of 405 ESGs were completed, with a mean operative time of 36.37 minutes. Early intraoperative complications included bleeding requiring adrenaline injection (1.75%) and submucosal hematoma (0.5%). No reinterventions were required, and the mean hospital stay was 6.3 hours. No other early complications were observed.
Conclusion:
ESG performed in a high-volume center demonstrated favorable safety profiles with minimal early complications, short operative times, and rapid recovery periods. These findings reinforce ESG as an effective and safe option for minimally invasive bariatric treatment in experienced settings.
Back to 2025 Posters
